Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT00472186
Other study ID # 06-11-0513
Secondary ID
Status Terminated
Phase Phase 4
First received
Last updated
Start date June 2008
Est. completion date February 2011

Study information

Verified date November 2021
Source Boston Children's Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study was designed to determine whether post-operative pain following a tonsillectomy can be reduced by adding an antacid-like medication to the medications taken after surgery. It is hypothesized that even a small amount of stomach acid backing up and entering the mouth can increase post-tonsillectomy pain. Therefore, the use of an antacid-like medication should help to decrease pain and reduce the amount of narcotic medication required for pain control.


Description:

This study has been limited to children and adolescents ages 5-18 who are undergoing tonsillectomy for an indication of obstructive sleep disturbance (snoring, choking/gasping or pauses in breathing during sleep.) Study participants will be randomized to two groups: study medication (Lansoprazole) or an inactive substance(placebo). Participants will be asked to do all of the following: 1. Take the study medication twice a day for 14 days. 2. Keep a log book which will include: - Record the medications and amount of each medication taken each day for 14 days. This includes pain medication and the study drug. - Record your child's activity level daily for 14 days. - Collect your child's urine one time daily and test it using special medicated strips to monitor their daily liquid intake for 14 days. 3. Meet with a Research Assistant or Study Physician 14-21 days after the study to collect the log book and perform a post-operative examination.


Recruitment information / eligibility

Status Terminated
Enrollment 2
Est. completion date February 2011
Est. primary completion date February 2011
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 5 Years to 18 Years
Eligibility Inclusion Criteria: - All healthy children ages 5-18 years scheduled for tonsillectomy and /or adenotonsillectomy for sleep disturbance secondary to airway obstruction at Children's Hospital Boston Exclusion Criteria: - Patients on any medications other than the study drug (Lansoprazole or placebo), Amoxicillin®, and acetaminophen with or without codeine - An underlying medical condition which would necessitate an alteration in the anesthetic regimen - Patients allergic to any of the medications in the protocol - History of chronic tonsillitis - History of chronic pain conditions - History of active gastro-esophageal reflux disease - Surgery in addition to tonsillectomy/adenotonsillectomy (except for myringotomy) - Cognitive/developmental disorders - Inability to use a self-report pain scale

Study Design


Intervention

Drug:
Lansoprazole
If weight is less than 30 kg, 15 mg of Lansoprazole twice daily will be administered. If weight is greater than or equal to 30 kg, 30 mg of Lansoprazole twice daily will be administered.
Placebo
Placebo will also be administered based on weight.

Locations

Country Name City State
United States Children's Hospital Boston Boston Massachusetts
United States Childrens Hospital Boston Boston Massachusetts

Sponsors (1)

Lead Sponsor Collaborator
Boston Children's Hospital

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary The Primary Outcome is the Number of Days to Become Free of Narcotic Pain Medication. 2 weeks
Secondary The Secondary Outcomes Are the Number of Days to be Free of Pain, the Number of Days to Return to Normal Activity Levels and the Number of Days to Return to Normal Fluid Intake. 2 weeks